A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2001
12/05/2001	CN1324636A Patent Chinese medicine for preventing lung cancer and relieving tabacism and preparation method thereof
12/05/2001	CN1324632A Tumor treating Chinese medicine prepn.
12/05/2001	CN1324624A Stomach and kidney disease treating medicine powder
12/05/2001	CN1324619A Health capsule of pure active chitosan and animal fiber
12/05/2001	CN1324613A Use of taxiol stabilized by albumin in preparing emdicine for treating body tumor and medicine obtained therefrom
12/05/2001	CN1075836C Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
12/05/2001	CN1075816C Methods for in vivo reduction of nitric oxide levels and compositions sueful therefor
12/05/2001	CN1075809C Novel vitamin D analogues
12/05/2001	CN1075802C Asiatic acid derivatives having modified A-ring
12/04/2001	USRE37462 Protein sequence of the plant toxin gelonin
12/04/2001	US6326510 Skin disorders; anticancer agents
12/04/2001	US6326507 Therapeutic compounds and methods of use
12/04/2001	US6326490 Antiproliferation agents or anticarcinogenic agents
12/04/2001	US6326464 Genetically engineered tumor suppressor protein; for use in the treatment of cancers; antiproliferative agents
12/04/2001	US6326403 Cardiovascular disorders
12/04/2001	US6326388 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
12/04/2001	US6326385 Administering poltassium channel modulator
12/04/2001	US6326378 Use of thiadiazolo[4,3-a]pyridine derivatives
12/04/2001	US6326367 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
12/04/2001	US6326357 Bacterial cell complex composition and method of use
12/04/2001	US6326356 Antitumor agents
12/04/2001	US6326355 Method for the prevention and treatment of cachexia and anorexia
12/04/2001	US6326353 123therapy for septic shock; administering polymyxin by injection
12/04/2001	US6326352 Compounds and methods for modulating cell adhesion
12/04/2001	US6326199 Hybridization and rnace activation in a cell with oligonucleotides
12/04/2001	CA2235565C Process for the preparation of rhus verniciflua extract and anti-cancer composition containing same
12/04/2001	CA2217953C A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
12/04/2001	CA2040982C N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use
12/04/2001	CA2024253C Entities for cancer therapy
11/2001
11/30/2001	CA2348847A1 New isoxazole-sulfonamide endothelin antagonists
11/29/2001	WO2001090404A1 Drug screening systems and assays
11/29/2001	WO2001090401A2 Yeast strains to identify specific inhibitors of polo kinases
11/29/2001	WO2001090390A1 Use of baculovirus vectors in gene therapy
11/29/2001	WO2001090361A2 Modulation of inflammation by protease-treated mcp-3 chemokine
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090332A2 Dna repair polypeptides and methods of use
11/29/2001	WO2001090330A2 AMINOACYL tRNA SYNTHETASES
11/29/2001	WO2001090316A2 Human circulating dendritic cell compositions and methods
11/29/2001	WO2001090315A2 Production of neurons from stem cells
11/29/2001	WO2001090313A2 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS
11/29/2001	WO2001090306A2 Compositions and methods for modulating tumor specific expression
11/29/2001	WO2001090198A1 Multicomponent conjugates which bind to target molecules and stimulate cell lysis
11/29/2001	WO2001090197A1 Synthetic peptides and uses therefore
11/29/2001	WO2001090192A2 Bispecific immunoglobulin-like antigen binding proteins and method of production
11/29/2001	WO2001090186A1 Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof
11/29/2001	WO2001090176A1 A novel polypeptide - human keratin 45.87 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090174A1 A novel polypeptide-human peroxisome fatty acid acetyl-coa oxidase 46.97 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090172A1 A novel polypeptide-human ribosomal l39 protein 13 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090171A1 A novel polypeptide-human robosomal sii protein 12 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090169A1 A novel polypeptide- human proliferating cell nuclear antigen (pcna) 13 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090159A2 Compositions and methods for delivery of a molecule into a cell
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001	WO2001090154A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
11/29/2001	WO2001090153A2 Reagents for cell selection and methods of use
11/29/2001	WO2001090152A2 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001	WO2001090148A2 Neurotransmitter transporters
11/29/2001	WO2001090136A2 Triterpenoid derivatives
11/29/2001	WO2001090114A1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation
11/29/2001	WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
11/29/2001	WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090096A2 Triterpenoid derivatives and their use as antiproliferative agents
11/29/2001	WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001	WO2001090076A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090069A1 Novel calcium receptor active molecules and method for preparing same
11/29/2001	WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	WO2001090064A2 COMPOSITION AND METHOD CONTAINING PRODUCTS EXTRACTED FROM COMMIPHORA Sp. FOR PREVENTION AND TREATMENT OF ABNORMAL CELL GROWTH AND PROLIFERATION IN INFLAMMATION, NEOPLASIA AND CARDIOVASCULAR DISEASE
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001090051A1 Phenylglycine derivatives
11/29/2001	WO2001090047A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	WO2001090046A1 Triterpenoid derivatives
11/29/2001	WO2001089581A1 Medicinal compositions containing prostacyclin synthase gene
11/29/2001	WO2001089580A1 Systemic and cardiovascular transduction with lentiviral vectors
11/29/2001	WO2001089577A2 Conjugates of aminodrugs comprising an oxime bond
11/29/2001	WO2001089576A2 Preparation hypericin bonded with poly-n-vinylamides
11/29/2001	WO2001089569A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
11/29/2001	WO2001089568A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001	WO2001089566A1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
11/29/2001	WO2001089565A1 Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity
11/29/2001	WO2001089564A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
11/29/2001	WO2001089552A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	WO2001089549A2 Therapeutic uses of il-1 receptor antagonist
11/29/2001	WO2001089542A2 Composition for improving the cell protection comprising a lipophilic antioxidant and a hydrophilic antioxidant
11/29/2001	WO2001089520A2 Dehydroascorbic acid formulations and uses thereof
11/29/2001	WO2001089516A1 Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition
11/29/2001	WO2001089515A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
11/29/2001	WO2001089504A1 Tropolone derivatives and pharmaceutical compositions
11/29/2001	WO2001089501A1 Polymerizable compositions and methods of use
11/29/2001	WO2001089499A2 Use of pyridinylimidazole carbamate derivate for the manufacture of a medicament for the treatment of cancer
11/29/2001	WO2001089494A2 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
11/29/2001	WO2001089481A1 Prolonged release microspheres for injection delivery and preparation method
11/29/2001	WO2001089449A2 Phospholipase d effectors for therapy and screening
11/29/2001	WO2001089282A2 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
11/29/2001	WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001	WO2001060810B1 Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity
11/29/2001	WO2001058935A3 FACTOR VII OR VIIa-LIKE MOLECULES
11/29/2001	WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof

1 ... 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 ... 2211